Sidong Huang
Molecular Biology · 2012–2014
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 16 citations into it
Whom Sidong Huang trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Sidong Huang's perspective
Ordered by how strongly the researchers Sidong Huang trusts endorse each paper. Same corpus, a different order for every researcher.
- Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. (Journal of Clinical Oncology)
- The Protein Kinase Complement of the Human Genome (Science)
- The Concept of Synthetic Lethality in the Context of Anticancer Therapy (Nature Reviews. Cancer)
- A large-scale RNAi screen in human cells identifies new components of the p53 pathway (Nature)
- Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification (Science)
- The phosphoinositide 3-kinase pathway. (Science)
- Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice (Nature Genetics)
- A MicroRNA Signature of Hypoxia (Molecular and Cellular Biology)
- A bivalent chromatin structure marks key developmental genes in embryonic stem cells. (Cell)
- HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. (Cancer Cell)
Their papers
- Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma (2014) — 815 citations
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR (2012) — 1,935 citations